Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Faisal Khurshid's Stock Ratings
Leerink Partners Analyst
Faisal Khurshid is an analyst at Leerink Partners. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
33.8%
Smart Score
Overall Average Return Percentile
88th
Number of Ratings
30
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/09/2025 | KYMR | Buy Now | Kymera Therapeutics | $89.04 | 32.52% | $70 → $118 | Maintains | Outperform | Get Alert | |
| 11/20/2025 | TRVI | Buy Now | Trevi Therapeutics | $12.61 | 26.93% | $13 → $16 | Maintains | Outperform | Get Alert | |
| 11/07/2025 | ABCL | Buy Now | AbCellera Biologics | $3.63 | 10.19% | → $4 | Downgrade | Outperform → Market Perform | Get Alert | |
| 10/21/2025 | GLPG | Buy Now | Galapagos | $31.02 | 28.95% | $29 → $40 | Upgrade | Market Perform → Outperform | Get Alert | |
| 09/25/2025 | CTNM | Buy Now | Contineum Therapeutics | $11.58 | 72.71% | → $20 | Initiates | → Outperform | Get Alert | |
| 09/12/2025 | PTGX | Buy Now | Protagonist Therapeutics | $94.83 | -23.02% | → $73 | Initiates | → Outperform | Get Alert | |
| 08/14/2025 | STTK | Buy Now | Shattuck Labs | $3.08 | -35.17% | $4 → $2 | Maintains | Outperform | Get Alert | |
| 07/10/2025 | RYTM | Buy Now | Rhythm Pharmaceuticals | $112.56 | -9.38% | $88 → $102 | Maintains | Outperform | Get Alert | |
| 07/07/2025 | ABCL | Buy Now | AbCellera Biologics | $3.63 | 37.74% | → $5 | Assumes | → Outperform | Get Alert | |
| 07/07/2025 | RYTM | Buy Now | Rhythm Pharmaceuticals | $112.56 | -21.82% | → $88 | Initiates | → Outperform | Get Alert | |
| 04/14/2025 | IRWD | Buy Now | Ironwood Pharmaceuticals | $3.58 | -72.07% | $3 → $1 | Maintains | Market Perform | Get Alert | |
| 04/08/2025 | SYRE | Buy Now | Spyre Therapeutics | $33.20 | 35.52% | → $45 | Initiates | → Outperform | Get Alert | |
| 03/17/2025 | NRIX | Buy Now | Nurix Therapeutics | $18.97 | -15.66% | → $16 | Initiates | → Market Perform | Get Alert | |
| 03/17/2025 | STTK | Buy Now | Shattuck Labs | $3.08 | 29.66% | → $4 | Initiates | → Outperform | Get Alert | |
| 03/03/2025 | PLRX | Buy Now | Pliant Therapeutics | $1.25 | 59.36% | $33 → $2 | Downgrade | Outperform → Market Perform | Get Alert | |
| 02/18/2025 | ATYR | Buy Now | aTyr Pharma | $0.74 | 2075.98% | → $16 | Initiates | → Outperform | Get Alert | |
| 12/27/2024 | KYMR | Buy Now | Kymera Therapeutics | $89.04 | -32.61% | $60 → $60 | Maintains | Outperform | Get Alert | |
| 12/11/2024 | ANIP | Buy Now | ANI Pharmaceuticals | $81.50 | -1.84% | → $80 | Initiates | → Outperform | Get Alert | |
| 11/04/2024 | ZURA | Buy Now | Zura Bio | $4.07 | 269% | → $15 | Initiates | → Outperform | Get Alert | |
| 09/09/2024 | TRVI | Buy Now | Trevi Therapeutics | $12.61 | -44.47% | → $7 | Assumes | → Outperform | Get Alert | |
| 09/09/2024 | PRTC | Buy Now | PureTech Health | $16.91 | 166.11% | → $45 | Assumes | → Outperform | Get Alert | |
| 09/09/2024 | PLRX | Buy Now | Pliant Therapeutics | $1.25 | 2529.48% | → $33 | Assumes | → Outperform | Get Alert | |
| 09/09/2024 | IRWD | Buy Now | Ironwood Pharmaceuticals | $3.58 | 39.66% | → $5 | Initiates | → Market Perform | Get Alert | |
| 09/09/2024 | GLPG | Buy Now | Galapagos | $31.02 | -22.63% | → $24 | Initiates | → Market Perform | Get Alert | |
| 09/09/2024 | GERN | Buy Now | Geron | $1.34 | 422.39% | → $7 | Initiates | → Outperform | Get Alert | |
| 09/09/2024 | MNKD | Buy Now | MannKind | $5.94 | 34.68% | → $8 | Assumes | → Outperform | Get Alert | |
| 09/09/2024 | KYMR | Buy Now | Kymera Therapeutics | $89.04 | -32.61% | → $60 | Assumes | → Outperform | Get Alert | |
| 09/09/2024 | IMUX | Buy Now | Immunic | $0.62 | 706.19% | → $5 | Assumes | → Outperform | Get Alert | |
| 03/19/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | $17 → $21 | Downgrade | Outperform → Market Perform | Get Alert | |
| 03/21/2023 | RAIN | Buy Now | Rain Oncology | $6.25 | 76% | → $11 | Initiates | → Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved